Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis
Authors
Keywords
ALS, Neuroinflammation, Withaferin A, SOD1<sup>G93A</sup>, SOD1<sup>G37R</sup>
Journal
Neurotherapeutics
Volume 12, Issue 1, Pages 217-233
Publisher
Springer Nature
Online
2014-11-22
DOI
10.1007/s13311-014-0311-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis
- (2014) Priyanka Patel et al. MOLECULAR THERAPY
- Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
- (2014) Ashley E. Frakes et al. NEURON
- Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract
- (2013) Pratima Sinha et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation
- (2013) J. A. SoRelle et al. DIABETOLOGIA
- Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival
- (2013) Smita Saxena et al. NEURON
- Characterization of early pathogenesis in the SOD1G93Amouse model of ALS: part I, background and methods
- (2013) Sharon Vinsant et al. Brain and Behavior
- Characterization of early pathogenesis in the SOD1G93Amouse model of ALS: part II, results and discussion
- (2013) Sharon Vinsant et al. Brain and Behavior
- The small heat shock proteins αB-crystallin and Hsp27 suppress SOD1 aggregation in vitro
- (2012) Justin J. Yerbury et al. CELL STRESS & CHAPERONES
- Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
- (2012) N. Ticozzi et al. CNS & Neurological Disorders-Drug Targets
- Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target
- (2012) E. Bogaert et al. CNS & Neurological Disorders-Drug Targets
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
- (2012) Jenny S. Henkel et al. EMBO Molecular Medicine
- GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia
- (2012) Bijay Parajuli et al. Journal of Neuroinflammation
- Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms
- (2012) Weihua Zhao et al. NEUROBIOLOGY OF DISEASE
- Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis
- (2012) Edward Pokrishevsky et al. PLoS One
- Withaferin A Induces Proteasome Inhibition, Endoplasmic Reticulum Stress, the Heat Shock Response and Acquisition of Thermotolerance
- (2012) Saad Khan et al. PLoS One
- Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS
- (2012) T. E. Brotherton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
- (2012) N. Sehgal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
- (2011) David R. Beers et al. BRAIN
- Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells
- (2011) Kyoung-jin Min et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways
- (2011) Vivek Swarup et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuronal Injury Marker ATF-3 Is Induced in Primary Afferent Neurons of Monoarthritic Rats
- (2011) Diana Nascimento et al. NEUROSIGNALS
- From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
- (2010) John M Lincecum et al. NATURE GENETICS
- Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
- (2010) Daryl A Bosco et al. NATURE NEUROSCIENCE
- Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis
- (2010) A. Malaspina et al. NEUROSCIENCE
- Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients
- (2010) Karin Forsberg et al. PLoS One
- Aggregation of Copper–Zinc Superoxide Dismutase in Familial and Sporadic ALS
- (2009) Madhuri Chattopadhyay et al. ANTIOXIDANTS & REDOX SIGNALING
- Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
- (2009) Siân C. Barber et al. FREE RADICAL BIOLOGY AND MEDICINE
- Live imaging of amyotrophic lateral sclerosis pathogenesis: Disease onset is characterized by marked induction of GFAP in Schwann cells
- (2009) A. Florence Keller et al. GLIA
- High frequency ofTARDBPgene mutations in Italian patients with amyotrophic lateral sclerosis
- (2009) Lucia Corrado et al. HUMAN MUTATION
- Withaferin A inhibits tumor necrosis factor-α-induced expression of cell adhesion molecules by inactivation of Akt and NF-κB in human pulmonary epithelial cells
- (2009) Jung Hwa Oh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis
- (2009) Akop Seksenyan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process
- (2009) Stefania Mantovani et al. JOURNAL OF NEUROIMMUNOLOGY
- Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
- (2009) J. Mellergård et al. Multiple Sclerosis Journal
- A role for motoneuron subtype–selective ER stress in disease manifestations of FALS mice
- (2009) Smita Saxena et al. NATURE NEUROSCIENCE
- TDP-43A315T mutation in familial motor neuron disease
- (2008) Michael A. Gitcho et al. ANNALS OF NEUROLOGY
- Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult
- (2008) Jae J. An et al. FEBS Journal
- TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis
- (2008) Vivianna M Van Deerlin et al. LANCET NEUROLOGY
- TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
- (2008) Edor Kabashi et al. NATURE GENETICS
- Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
- (2008) Rebecca Banerjee et al. PLoS One
- CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
- (2008) D. R. Beers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS
- (2008) I. M. Chiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
- (2008) J. Sreedharan et al. SCIENCE
- Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury
- (2008) Pierre Cordeau et al. STROKE
- Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression
- (2007) Paul S. Sharp et al. NEUROBIOLOGY OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started